EMA — authorised 29 November 2009
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Arcapta Neohaler in European Union
EMA authorised Arcapta Neohaler on 29 November 2009
Marketing authorisation
Arcapta Neohaler in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in European Union
Frequently asked questions
Is Arcapta Neohaler approved in European Union?
Yes. EMA authorised it on 29 November 2009.
Who is the marketing authorisation holder for Arcapta Neohaler in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.